Intec Pharma Names Nir Sassi CFO, Effective Aug. 1, Succeeding Oren Mohar

(RTTNews) - Intec Pharma Ltd. (NTEC), a clinical stage biopharmaceutical company, announced Friday that it has appointed Nir Sassi, the Company's VP Finance, as the Chief Financial Officer of the company effective as of August 1. Sassi replaces Oren Mohar, who has resigned due to personal reasons.

Zeev Weiss, the Company's Chief Executive Officerand director said, "During his term as the company's Chief Financial Officer, which also included the company's initial public offering in the U.S, Oren made a significant contribution to Intec. Throughout Oren's time with Intec, he was well respected for his professionality and high level of integrity."

Mohar said, "... I am highly confident in Intec's continued success in the coming years."